Antibiotics for COPD Exacerbations
Author Information
Author(s): Milo Puhan, Daniela Vollenweider, Tsogyal Latshang, Johann Steurer, Claudia Steurer-Stey
Primary Institution: Horten Centre, University Hospital of Zurich
Hypothesis
The study aims to analyze the clinical benefit of antibiotics for patients suffering from exacerbations of chronic obstructive pulmonary disease (COPD).
Conclusion
Antibiotics effectively reduce treatment failure and mortality rates in COPD patients with severe exacerbations, but may not be indicated for those with mild to moderate exacerbations.
Supporting Evidence
- Antibiotics did not reduce treatment failures in outpatients with mild to moderate exacerbations.
- Inpatients with severe exacerbations had a substantial benefit on treatment failure rates.
- The number-needed to treat to prevent one death in severe exacerbations was 14.
Takeaway
If someone with COPD gets worse, antibiotics can help if they're really sick, but if they're just a little sick, they might not need them.
Methodology
A systematic review of randomized, placebo-controlled trials assessing the effects of antibiotics on treatment failure in COPD patients.
Potential Biases
Potential selection bias due to exclusion of non-randomized trials and varying definitions of outcomes.
Limitations
Definitions of treatment failure varied across trials, and severity of underlying COPD could not be compared due to inconsistent reporting.
Participant Demographics
Included 1557 COPD patients, with varying severity of exacerbations and demographics reported across trials.
Statistical Information
P-Value
0.016
Confidence Interval
95% CI 0.75–1.59 for mild to moderate exacerbations; 95% CI 0.16–0.39 for severe exacerbations
Statistical Significance
p = 0.016
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website